Giselle Fernandes Taboada

Quantitative analysis of somatostatin receptor subtype (SSTR1–5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

Giselle Fernandes Taboada, Raúl M. Luque, Wildebranham Bastos et al. · European Journal of Endocrinology · 2007 · 222 citations

Medicine, Endocrinology, Oncology +17

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

Giselle Fernandes Taboada, Raúl M. Luque, Leonardo Vieira Neto et al. · European Journal of Endocrinology · 2008 · 172 citations

Medicine, Endocrinology, Oncology +17

Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly

Leonardo Vieira Neto, Raúl M. Luque, Giselle Fernandes Taboada et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 140 citations · Full text

Medicine, Endocrinology, Oncology +17

Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas

Raúl M. Luque, Alejandro Ibáñez‐Costa, Leonardo Vieira Neto et al. · Cancer Letters · 2015 · 89 citations

Medicine, Endocrinology, Oncology +7

Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging.

Flavia Regina Barbosa Van Haute, Giselle Fernandes Taboada, Lívia L. Corrêa et al. · European Journal of Endocrinology · 2008 · 88 citations

Medicine, Endocrinology, Maxillofacial Radiology +15